| Integrative analysis identifies four molecular and clinical subsets in uveal melanoma AG Robertson, J Shih, C Yau, EA Gibb, J Oba, KL Mungall, JM Hess, ... Cancer cell 32 (2), 204-220. e15, 2017 | 799 | 2017 |
| CD38-mediated immunosuppression as a mechanism of tumor cell escape from PD-1/PD-L1 blockade L Chen, L Diao, Y Yang, X Yi, BL Rodriguez, Y Li, PA Villalobos, ... Cancer discovery 8 (9), 1156-1175, 2018 | 367 | 2018 |
| Uveal melanoma: From diagnosis to treatment and the science in between C Chattopadhyay, DW Kim, DS Gombos, J Oba, Y Qin, MD Williams, ... Cancer 122 (15), 2299-2312, 2016 | 359 | 2016 |
| Novel algorithmic approach predicts tumor mutation load and correlates with immunotherapy clinical outcomes using a defined gene mutation set J Roszik, LE Haydu, KR Hess, J Oba, AY Joon, AE Siroy, TV Karpinets, ... BMC medicine 14, 1-8, 2016 | 125 | 2016 |
| Clinicopathologic and prognostic significance of SATB1 in cutaneous malignant melanoma H Chen, M Takahara, J Oba, L Xie, T Chiba, S Takeuchi, Y Tu, ... Journal of dermatological science 64 (1), 39-44, 2011 | 77 | 2011 |
| Expression of c-Kit, p-ERK and cyclin D1 in malignant melanoma: an immunohistochemical study and analysis of prognostic value J Oba, T Nakahara, T Abe, A Hagihara, Y Moroi, M Furue Journal of dermatological science 62 (2), 116-123, 2011 | 68 | 2011 |
| Expression of CD10 predicts tumor progression and unfavorable prognosis in malignant melanoma J Oba, T Nakahara, S Hayashida, M Kido, L Xie, M Takahara, H Uchi, ... Journal of the American Academy of Dermatology 65 (6), 1152-1160, 2011 | 46 | 2011 |
| Elevated serum leptin levels are associated with an increased risk of sentinel lymph node metastasis in cutaneous melanoma J Oba, W Wei, JE Gershenwald, MM Johnson, CM Wyatt, JA Ellerhorst, ... Medicine 95 (11), e3073, 2016 | 45 | 2016 |
| Elevated endogenous SDHA drives pathological metabolism in highly metastatic uveal melanoma C Chattopadhyay, J Oba, J Roszik, JR Marszalek, K Chen, Y Qi, ... Investigative Ophthalmology & Visual Science 60 (13), 4187-4195, 2019 | 36 | 2019 |
| Expression of milk fat globule epidermal growth factor‐VIII may be an indicator of poor prognosis in malignant melanoma J Oba, Y Moroi, T Nakahara, T Abe, A Hagihara, M Furue British Journal of Dermatology 165 (3), 506-512, 2011 | 34 | 2011 |
| RT-PCR screening tests for SARS-CoV-2 with saliva samples in asymptomatic people: strategy to maintain social and economic activities while reducing the risk of spreading the virus J Oba, H Taniguchi, M Sato, R Takamatsu, S Morikawa, T Nakagawa, ... The Keio Journal of Medicine 70 (2), 35-43, 2021 | 31 | 2021 |
| Expression of programmed death receptor ligand 1 in melanoma may indicate tumor progression and poor patient survival J Oba, T Nakahara, T Abe, A Hagihara, Y Moroi, M Furue Journal of the American Academy of Dermatology 70 (5), 954-956, 2014 | 29 | 2014 |
| CD10-bearing fibroblasts may inhibit skin inflammation by down-modulating substance P L Xie, M Takahara, T Nakahara, J Oba, H Uchi, S Takeuchi, Y Moroi, ... Archives of Dermatological Research 303, 49-55, 2011 | 23 | 2011 |
| Reprogramming of bivalent chromatin states in NRAS mutant melanoma suggests PRC2 inhibition as a therapeutic strategy CJ Terranova, M Tang, M Maitituoheti, AT Raman, AK Ghosh, J Schulz, ... Cell reports 36 (3), 2021 | 20 | 2021 |
| Targeting the HGF/MET axis counters primary resistance to KIT inhibition in KIT-Mutant Melanoma J Oba, SH Kim, WL Wang, MP Macedo, F Carapeto, MA McKean, ... JCO precision oncology 2, 2018 | 18 | 2018 |
| Case of adult T‐cell leukemia/lymphoma manifesting marked purpura J Okada, S Imafuku, J Tsujita, Y Moroi, K Urabe, M Furue The Journal of Dermatology 34 (11), 782-785, 2007 | 18 | 2007 |
| Estimating copy number using next-generation sequencing to determine ERBB2 amplification status K Nakamura, E Aimono, J Oba, H Hayashi, S Tanishima, T Hayashida, ... Medical Oncology 38, 1-8, 2021 | 17 | 2021 |
| Early tumor-infiltrating dendritic cells change their characteristics drastically in association with murine melanoma progression T Nakahara, J Oba, C Shimomura, M Kido-Nakahara, M Furue Journal of Investigative Dermatology 136 (1), 146-153, 2016 | 17 | 2016 |
| The prognostic value of a reverse transcriptase-PCR assay of sentinel lymph node biopsy for patients with cutaneous melanoma: a single-center analysis in Japan T Ito, Y Moroi, J Oba, T Nakahara, S Takeuchi, H Uchi, M Takahara, ... Melanoma research 22 (1), 38-44, 2012 | 14 | 2012 |
| Hair follicle nevus–a dermoscopic approach J Okada, Y Moroi, J Tsujita, M Takahara, K Urabe, H Kiryu, M Furue European Journal of Dermatology 18 (2), 185-187, 2008 | 14 | 2008 |
